baber/WOPTO huggingface dataset:
Patent JP-H06224783-A (JP)
Title: Cyclic coded crc device
Inventor: SAEGUSA YASUHIRO
IPC: H04L1/00
Filed: 1993-01-25
Abstract: PURPOSE:To shorten processing time of cyclic coding and a CRC processing using a computer and to effectively utilize the computer for the other processings by providing a remainder table storage means in which 2n pieces of high-order tables are stored beforehand. CONSTITUTION:A CPU 100 sets the number of times of loops at '5', reads 8-bit data from a memory 300, defines them as input data and reads first remainder data from a table ROM 200 with the input data as an address. The next 8-bit data are read from the memory 300 to let them be input and low-order 4 bits are saved to let them be first save data. Then, high-order 4 bits are shifted to the low-order 4 bits, let them be first shift data and both first remainder and shift data are synthesized. With them as the address, second remainder data are read from the ROM 200 to be synthesized with the first save data and let the result be second synthetic data. Then, third remainder data are read form the ROM 200 with the second synthetic data as the address and the number of times of the loops (for instance: '5'.) with a 4-bit unit arithmetic processing the number of times of the loops (for instance: '5'.) is reiterated.
Patent JP-S61169852-A (JP)
Title: Image recording material
Inventor: HARUTA MASAHIRO
IPC: G03G5/026
Filed: 1985-01-24
Abstract: PURPOSE:To execute production and recording without exercising special care for photosensitivity and to make possible the long-term stable preservation of an image by using a recording material formed with a specifically constituted recording layer and photosensitive layer on a conductive base. CONSTITUTION:The image recording material 10 is constituted by forming the recording layer 2 consisting of a colored electrolytically polymerized film on the conductive substrate 1 and forming further the photosensitive layer 3 consisting of a polymer complex composed of a basic polymer and acidic polymer and a sensitizer thereon. The recording is executed by placing an original onto the material 10 and exposing the same with active rays to form a latent image then immersing the material into an electrolyte and conducting electricity thereto to develop the image. The recording layer 2 and the photosensitive layer 3 do not lose the photosensitivity even after resting in an ordinary atmosphere and no special care is required in the stage of production. The recording is easy and the polymer complex is stable after development. The long-term stable preservation of the image is thus realized.
Patent MX-161936-A (MX)
Inventor: KAMIENICKI EMIL
IPC: G03G15/00
Filed: 1986-04-03
Abstract: A method and apparatus are described for the nondestructive readout of a latent electrostatic image formed on a sheet or layer of insulating material. A sheet or layer of semiconductor material is disposed in relatively close proximity to the insulating material forming a multi-layer material (41). The latent electrostatic image formed on the insulating material causes a surface depletion layer to be produced by induction at the surface of the semiconductor material. The location and distribution of the accumulated charges on the semiconductor material are read out by electronic circuits (59) as analog electrical signals corresponding to the ac surface photovoltage induced on the semiconductor material as the semiconductor material is scanned with a low intensity modulated light beam of appropriate wavelength generated by light source (53), the magnitude of the analog signals depending on the local charge density. The analog electrical signals so obtained are then digitized (61), processed (63) and stored and/or displayed (65).
Patent MX-160956-A (MX)
Inventor: KING PATRICK DANA
IPC: F16K3/02
Filed: 1984-03-23
Abstract: A sliding gate valve assembly employed on the side of a furnace as a furnace valve is so structured that the shut off of metal flow from the furnace occurs by directing the slide gate (21) to the up position rather than the down position. In addition, to facilitate a reduction in space at the slide gate, the slide gate is desirably configured to be asymmetrical, with the short end extending upwardly from the pour opening (29) in the nozzle. A refractory lined heat shield (26) protects the sliding gate carrier (22) and also serves to mount a collector extension (30) when used. The slide gate (21) is provided with a metallic frame (60) which retains a monolithic refractory (80) into which erosion resistant refractory inserts or performed members (29,70) are cast. Means are desirably provided to remove the spent refractory for remanufacture thereby reclaiming the casting. Similarly in the stationary plate (20), means are provided for remanufacture and for facilitating proper orientation of erosion-resistant refractory inserts in the manufacture of the stationary plate. The stationary plate is symmetrical to provide full travel pressure face relationship with the sliding gate (21). Both the stationary plate (20) and slide gate (21) casting have spring pad back up reinforcements. The statutory plate desirably has means for securing a well nozzle (19) to it.
Patent TR-24658-A (TR)
IPC: G11B7/09
Filed: 1990-10-26
Abstract: The invention concerns an optical scanning device which scans the frequency-warbled data tracks of a recording medium, the scanning light beam being reflected from the recording medium on to a four-quadrant photodetector (PD) with four photodiodes (A, B, C, D). In order to be able to compensate automatically for offset voltages produced in the focussing-control loop by, for instance, temperature fluctuations, the focussing signal and the track error signal are input into a multiplier circuit (M). The multiplier output is fed through a low-pass filter (TP) and as a compensation voltage to the focussing-control loop.
Patent YU-161685-A (YU)
Title: Process for obtaining antiinflamatoric salts of pyroxicame
Inventor: LOMBARDINO J G
IPC: C07D417/12
Filed: 1985-10-10
Abstract: Improved antiinflammatory salts of piroxicam consist of a 1 : 1 salt of piroxicam with antidepressant doxepin, with bronchodilator pirbuterol or isoproterenol, with H<sub>2</sub>-antagonist inhibitor 2-guanidino-4-(2-methyl-4-imidazolyl)thiazole, with pyridoxine, a member of the vitamin B<sub>6</sub> complex, or with anti- hypertensive trimazosin.
Patent YU-163488-A (YU)
Title: Binder for closing packaging shaped as tube or bag, especially tube like ones, with nutrition products inside
Inventor: MADESN E
IPC: A22C11/12
Filed: 1988-08-29
Abstract: The closing of tubular casings containing foodstuffs by mounting a binder on a constriction of the casing involves the traditional problem of a high waste percentage due to the binders either damaging the casing material or sliding off the constriction. A method and a binder are proposed which makes it possible to obtain a very strong clamping of the binder without damaging the casing material, and, in connection with tight plastic casings, it is even possible to provide a "super tight" closure, by ranging the constriction with an oblong cross section between opposed straight clamping beams, which are forced together so as to produce a controlled deformation flowing of the casing material.
Patent YU-168489-A (YU)
Title: Derivatives of cycloalkyl-substituted glutakamide, process for obtaining and mixtures containing them
Inventor: CH DANILEWICZ J
IPC: C07D209/20
Filed: 1989-09-04
Abstract: Compounds of the formula: <CHEM> Wherein A completes a 5 or 6 membered carbocyclic ring which may be saturated or monounsaturated; R<1> is H or (C1-C4)alkyl; R and R<4> are H, (C1-C6)alkyl, C3-C7 cycloalkyl, benzyl, or an alternative biolabile ester-forming group; Y is either a direct bond or an alkylene group of from 1 to 6 carbon atoms; R<2> is H, aryl, heterocyclyl, R<6>CONR<5>-, R<7>NR<5>CO-, R<7>NR<5>SO2- or R<8>SO2NR<5>-, with the proviso that Y is not a direct bond when R<2> is H, aryl or heterocyclyl; wherein R<5> is H, (C1-C6)alkyl or aryl(C1-C6)alkyl; R<6> is (C1-C6)alkyl, aryl, aryl(C1-C6)alkyl, heterocyclyl, heterocyclyl(C1-C6)alkyl or a group of the formula R<9>R<1><0>R<1><1>C- wherein R<9> is H, OH, (C1-C6)alkoxy, (C1-C6)alkyl, hydroxy(C1-C6)alkyl, aryl(C1-C6)alkyl, (C2-C6)alkenyl, heterocyclyl, heterocyclyl(C1-C6)alkyl, R<1><2>CONH-, R<1><2>SO2NH- or (R<1><3>)2N-; R<1><0> and R<1><1> are H or (C1-C6)alkyl; or R<1><0> is H and R<1><1> is amino(C1-C6)alkyl, imidazolylmethyl, aryl, aryl(C1-C6)alkyl, aryl(C1-C6)alkoxy(C1-C6)alkoxy, hydroxy(C1-C6)alkyl or methylthio(C1-C6)alkyl; or the two groups R<1><0> and R<1><1> form a 3 to 6 membered carbocyclic ring or a pyrrolidine or piperidine ring which may optionally be substituted by amino, (C2-C4)alkanoyl or aroyl; R<1><2> is (C1-C6)alkyl, (C3-C7)cycloalkyl, aryl, aryl(C1-C6)alkyl, heterocyclyl or heterocyclyl(C1-C6)alkyl; each R<1><3> is H, (C1-C6)alkyl, aryl(C1-C6)alkyl or the two groups R<1><3> form a pyrrolidinyl, piperidino, morpholino, piperazinyl or N-(C1-C4)alkyl-piperazinyl group; R<7> is (C1-C6)alkyl, aryl, aryl(C1-C6)alkyl, heterocyclyl, heterocyclyl(C1-C6)alkyl or a group of the formula R<1><0>R<1><1>R<1><4>C- wherein R<1><0> and R<1><1> are as previously defined and R<1><4> is (R<1><3>)2NCO-, R<1><2>OCH2- or R<1><5>OCO, wherein R<1><2> and R<1><3> are as previously defined and R<1><5> is (C1-C6)alkyl, (C3-C7)cycloalkyl or aryl(C1-C6)alkyl; and R<8> is (C1-C6)alkyl, aryl, aryl(C1-C6)alkyl, heterocyclyl or heterocyclyl(C1-C6)alkyl;  R<3> is a group of the formula: <CHEM> wherein R<1><6> is H, halo, 4-OH, 4-(C1-C6 alkoxy), 4-(C3-C7 cycloalkoxy) 4-(C2-C6 alkenyloxy), 4-[(C1-C6 alkoxy)carbonyloxy], 4-[(C3-C7 cycloalkoxy)carbonyloxy], or 3-(C1-C4 alkyl)SO2NH-; and R<2><0> is H, C1-C4 alkyl, C1-C4 alkoxy, C2-C6 alkanoyl or halo; or R<3> is a group of the formula: <CHEM> wherein said groups may optionally be substituted in the fused benzene ring by C1-C4 alkyl, C1-C4 alkoxy, OH, halo or CF3; are antihypertensive agents of utility in the treatment of hypertension, heart failure and renal insufficiency.
Patent YU-183791-A (YU)
Title: Gradjevinski blok
Inventor: PETRUS NAUDE S
IPC: E04B2/18
Filed: 1991-11-22
Abstract: GRADJEVINSKI BLOK, pronalazak se odnosi na medjusobno povezujući gradjevinski blok (10) bez maltera. Gradjevinski blok sadrži par naspramnih većih bočnih površina (12, 14), par naspramnih manjih ivičnih površina (16, 18) i par naspramnih većih gornjih i donjih površina (24, 26), pri čemu gornja ili donja površina imaju profil, kada se gleda u pravcu normalnom na ivične površine, sa jednim spoljnim polukanalom (82) i jednim unutrašnjim potpunim kanalom (88) naizmenično sa unutrašnjom unutrašnjom potpunom projekcijom (86) i spoljnom poluprojekcijom (84). Polukanal i poluprojekcija imaju polovinu sirine punog kanala i potpune projekcije, a kanali i projekcije se pružaju uzdužno izmedju naspramnih ivičnih površina (16, 18) bloka. Naspramna donja ili gornja površina (26, 24) bloka je simetrična u odnosu na imaginarnu osu (38) koja se pruža poprečno izmedju naspramnih bočnih površina i deli donju ili gornju površinu na dve jednake polovine (102, 104). Svaka polovina ima profil, koji kada se gleda normalno na veće bočne površine, sadrži poluprojekciju (40, 42) i potpunu projekciju (50, 52) naizmenično sa potpunim kanalom (44, 46) i polukanalom (48), od kojih se sve pružaju poprečno izmedju suprotnih bočnih površina, i koje su komplementarne sa kanalima i projekcijama na naspramnoj gornjoj ili donjoj površini. Par otvora (20, 22) pruža se izmedju gornjih i donjih površina, pri čemu su otvori podeljeni unutrašnjom čijom (28) koja se pruža poprečno izmedju naspramnih bočnih zidova (30, 32) bloka paralelno sa ivičnim zidovima (34, 36).
Patent YU-40702-A (YU)
Inventor: SA& X C ;AKOVIC MIROLJUB
Filed: 2002-06-04
Abstract: Membranski ventil sigurnosti je iz oblasti mašinstva a maksimalni ulazni pritisak u ventil je 5 bar. Karakteristično za ventil sigurnosti je to što je prostor izmedju membrane (4) i donjeg kućišta (1) spojen sa izlazom membranskog ventila. Spoj je ostavaren pomoću klipnog provlakača (12) koji prolazi kroz membranu (4) i čvrsto je vezan u nastavku za odstojnik (11) i impulsnu cev (13). Na donji kraj klipnog povlakača (12) deluje sila opruge (5) u sklopu sa membranom (4). Prostor ispod membrane (4) je hermetičan a hermetičnost je obezbedjena pomoću poklopca (6). Ukoliko ulazni pritisak toliko poraste da savlada silu opruge (5) dolazi do otvaranja ventila tako što se gumeni umetak (9) pomeri prema dole i odvoji od ulaznog priključka (7). Gas prolazi kroz impulsnu cev (13) i klipni provlakač (12) i dolazi sa donje strane membrane (4) čime se postiže preciznije otvaranje i zatvaranje ventila sigurnosti bez gubitka gasa.
Patent YU-93301-A (YU)
Inventor: STANKOVIC SLOBODAN
Filed: 2001-12-28
Abstract: Razvijen je jednostavan, nov, originalan i za primenu pogodan postupak dobijanja jedinjenja iz grupe heterocikličnih aminoalkil benzamida opšte formule I, i/ili njihovih soli i/ili hidrata i/ili optičkih izomera, gde R1 i R2 označavaju C1-C4 alkil grupu R3 označava aminosulfonil grupu, R4 označava atom vodonika ili amino grupu, R5 označava atom vodonika ili halogena, a koeficijenti m i n imaju vrednost 1 i/ili 2. Poseban interes u kliničkoj praksi imaju sulpirid (RS, R+ ili S-)-(5-(aminosulfonil)-N-/(1-etil-2-pirolidinil)metil/-2-metoksibenzamid) i sulmeprid (RS, R+ ili S-)-(5-(aminosulfonil)-2-metoksi-N-/(1-metil-2-pirolidinil)metil/benzamid). Jedinjenja iz ove grupe se primenjuju u terapiji kao: antipsihotici, antidepresanti, antiemetici, fungicidi, za izradu kontraceptivnih smeša u lečenju steriliteta, radiofarmaceutske kompozicije u nuklearnoj medicini, u lečenju migrene različitog porekla, kao i u lečenju Parkinsonove bolesti. Prednost navedenog pronalaska je u potpuno novom jednostavnom načinu izvodjenja sinteze heterocikličnih aminoalkil benzamida i/ili njihovih soli i/ili hidrata, reakcijom 2-alkoksi-5-sulfamoil-alkil benzoata sa odgovarajućim (RS, R+ ili S-) heterocikličnim aminom. Niža temperatura reakcije i rad na atmosferskom pritisku bez korišćenja katalizatora, izvodjenje reakcije u jeftinijim i za rad bezbednijim organskim rastvaračima, uz dobijanje finalnog proizvoda bez naknadnih prečišćavanja, ostvarivanje dobrog prinosa i visok kvalitet finalnog proizvoda, jeftiniji postupak za industrijsku primenu i dobijanje proizvoda visoke farmakopejske čistoće.
Patent AP-799-A (AP)
Title: Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl) phenylalkyl]-azaheterocyclylamide compounds.
Inventor: EWING WILLIAM R
IPC: A61P7/02
Filed: 1996-06-07
Granted: 2000-01-19
Abstract: The compounds of formula (I) exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More especially, they are inhibitors of the activity of Factor Xa. The present invention is directed to compounds of formula (I) , compositions containing compounds of formula (I) , and their use, which are for treating a patient suffering from, or subject to, physiological condition which can be ameliorated by the administration of an inhibitor of the activity of Factor Xa.
Patent AT-A6252003-A (AT)
Inventor: KORPAN NIKOLAI N DR
IPC: A61N2/12
Filed: 2003-04-24
Abstract: A device for detecting and influencing the physiological and/or pathological state of the human or animal body, including a housing which has a first housing wall that, in turn, has an outer surface provided for placing against a body to be treated. A rotor is situated inside the housing and is rotationally driven about an axis that is essentially perpendicular to the first housing wall. First magnets are mounted on the rotor, and their magnetic fields are oriented in the same direction that is parallel to the rotation axis. At least one additional magnet is situated essentially coaxial to the rotation axis with a polarity of each being oriented in an opposite direction to the first magnets.
Patent AU-1031697-A (AU)
Title: Novel geranylgeranyl-derivatives, process for the preparation thereof and related pharmaceutical compositions
Inventor: BALSAMO ALDO
IPC: C07C307/06
Filed: 1996-11-21
Abstract: The present invention relates to novel geranylgeranyl derivatives and the pharmaceutically acceptable salts thereof having antiproliferative activity in eukaryotic cells with respect to the inhibition of protein geranygeranylation. The invention also relates to the pharmaceutical compositions containing the novel derivatives and to the process of preparation thereof.
Patent AU-1034995-A (AU)
Title: A device for sealing of concrete joints
Inventor: HABBERSTAD BENT JOHN
IPC: E04B1/68
Filed: 1994-11-07
Abstract: PCT No. PCT/NO94/00176 Sec. 371 Date Apr. 30, 1996 Sec. 102(e) Date Apr. 30, 1996 PCT Filed Nov. 7, 1994 PCT Pub. No. WO95/13438 PCT Pub. Date May 18, 1995A device for sealing concrete joints is provided. The sealing device includes an elongate section (8) having a larger width than thickness (t). The section (8) has longitudinal edge portions (12, 13) and is intended for casting into two concrete structures (1, 2) for sealing a concrete joint area between the two structures (1,2). A swellable material (7, 14) is provided at least at the longitudinal edge portions (12, 13) thereof. The section (8) is made of a substantially rigid material and is provided with an internal cavity extending over a major part of its width.
Patent AU-1099688-A (AU)
Title: Substituted 3-phenyl-7h-thiazolo(2,2-b)(1,2,4)triazin-7-ones, a process for the preparation thereof, medicaments containing same and the use thereof, and also some intermediates formed in the preparation of the compounds mentioned
Inventor: THORWART WERNER
IPC: C07D513/04
Filed: 1988-01-29
Abstract: Novel substituted 3-phenyl-7H-thiazolo[3,2-b][1,2,4]-triazin-7-ones of the formula I are disclosed   <IMAGE> (I)  in which R1, R2 and R3 have the meaning recited in the specification. The compounds are suitable for prevention and treatment of inflammatory disorders.
Patent AU-1104097-A (AU)
Title: Call setup gateway for telecommunications system
Inventor: LOW COLIN
IPC: H04M3/00
Filed: 1996-12-11
Abstract: A third-party call setup gateway (90) is provided for setting up bearer channels through a switched telecommunications system, such as a PSTN, by controlling an associated switch (41). The call setup gateway (90) has an interface to the public internet (50). A first user (A) wishing to place a call to a second user (B) sends the call setup gateway (90) both the first user's telephone number (A-telnb) and a personal number (B-Webtel) of the second user. The gateway uses a phone page (49) or a server (51) connected to the Internet (50) to determine the current telephone number for the second user. The gateway then commands the switch to establish a call between the telephones of the first and second users. <IMAGE>
Patent AU-1136295-A (AU)
Title: Power amplifier for mobile station
Inventor: GOURGUE FREDERIC
IPC: H03G3/20
Filed: 1995-01-25
Abstract: The apparatus receives an amplified input signal and a biassing signal and produces an output amplified signal. The amplifier (1) has at least two distinct possible output power values and output signals (3) are emitted in a predetermined frequency band. A biassing control device (6) receives linear control information and generates the biassing signal (4). The biassing signal is a function of the linear control information and the real level of an out of band emission equal to a desired out of band emission level. The real level of the out of band signal is defined as a maximum predetermined threshold level. It does not matter which distinct power value is output.
Patent AU-1169999-A (AU)
Title: Aqueous ophthalmic formulations comprising chitosan
Inventor: GURNY ROBERT
IPC: A61K9/00
Filed: 1998-11-20
Abstract: A use of chitosan salt is disclosed, said salt having a deacetylation degree of 50 - 90 % and a molecular weight of 80,000 - 5,000,000 Da for the preparation of an aqueous ophthalmic formulation to be used as artificial tears having antimicrobial activity. The chitosan salt is used in an amount of 0.05 - 3 wt/v % based on the total aqueous ophthalmic formulation, said ophthalmic formulation having a viscosity of 10 - 500 mPa.s and a physiologically acceptable pH. The artificial tears obtained are particularly advantageous to treat dry eye syndrome and to prevent and cure infections or surinfections inherent to the treatment of dry eye.
Patent AU-1334495-A (AU)
Title: Oligonucleotides and methods for the detection of (chlamydia trachomatis)
Inventor: BURCZAK JOHN D
IPC: C12Q1/689
Filed: 1994-08-18
Abstract: The present invention relates to oligonucleotide probes useful in detecting, e.g. by hybridization or the ligase chain reaction, Chlamydia trachomatis DNA in the presence of other related DNA. The present invention is also directed to methods of detecting Chlamydia trachomatis organisms in a sample using the ligase chain reaction.
Patent AU-1449900-A (AU)
Title: Network presence for a communications system operating over a computer network
Inventor: GARDELL STEVEN E
IPC: H04M7/00
Filed: 1999-10-22
Abstract: A method and apparatus are implemented for providing traditional telecommunications service capabilities in a packet based computer network. The system and method of the present invention automatically provide such service capabilities in the event a terminal end-point is unavailable to receive an incoming call, based upon predetermined associations between the terminal end-point and one or more of the available services.
Patent AU-1458100-A (AU)
Title: Atomizing pump spray
Inventor: OLEGNOWICZ ISRAEL
IPC: B05B11/00
Filed: 1999-10-29
Abstract: The invention relates to a manual, self-priming precompression spray pump, which employs a minimal number of different parts. The assembly includes a container for the liquid, a cap, a conventional spray nozzle unit, a valve member, a piston, a spring and a cylinder for housing the piston and providing a compression chamber. The valve upper end functions as an outlet valve and the valve lower end functions as an inlet valve. The spring is a compound spring and serves to force the valve outlet end into a constant sealing engagement with the interior of the piston, and to resist the compression movement of the piston. The cylinder for housing the piston includes an inner, concentric valve cylinder. The inner cylindrical wall has an axial length which terminates short of the chevron valve when said valve member and said piston are fully biased away from said inlet valve, whereby said chevron valve is in a position outside of said inner cylindrical wall. Thus, at this extreme position, the inlet valve is fully open for cooperation with said piston cylinder inlet end to restrict liquid flow from out of said piston compression chamber and through said piston cylinder inlet end.
Patent AU-1623197-A (AU)
Title: Process for preparing calcium pyruvate and its hydrates
Inventor: ZIMMERMANN CURT
IPC: C07C51/50
Filed: 1997-03-11
Abstract: Preparation of very pure calcium pyruvate (I) or its hydrate (IA) by reacting an aqueous solution of pyruvic acid (II) with an inorganic calcium compound (III) at pH 2-7, preferably 2.5-4. A 10% aqueous (II) solution is reacted with (III), optionally in the presence of a stabiliser or complex forming agent. The resultant solution is mixed with an organic diluent at 0-30 degrees C. The resultant precipitate of (I) or (IA) is isolated from the solution.
Patent AU-1676999-A (AU)
Title: Ultrasonography of the prostate
Inventor: ERIKSEN MORTEN
IPC: A61B8/00
Filed: 1998-12-17
Abstract: Prostate abnormalities such as cancer may be detected by ultrasonic determination of the in-flow kinetics of contrast agent-containing blood in the prostate and/or by observation of disease-related asymmetries in the the spoke-like vascular pattern of the prostate.